A phase I dose-escalation study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced solid tumors.Patricia LoRusso,Mrinal M. Gounder,Manish R. Patel,Noboru Yamamoto,Todd Michael Bauer,Scott Laurie,Rolf Grempler,Teffany Davenport,Junxian Geng, Maren Rohrbacher,Mehdi LahmarJOURNAL OF CLINICAL ONCOLOGY(2021)引用 8|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要